Clinical Report: Increased Levels of GDF15 in Ocular Fluids of PDR Patients

Overview

This study reveals significantly elevated levels of GDF15 in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy (PDR) compared to control groups.

Background

Proliferative diabetic retinopathy is a severe complication of diabetes characterized by retinal neovascularization and associated with inflammation and oxidative stress. Understanding the local expression of biomarkers like GDF15 in the intraocular environment may provide insights into the mechanisms underlying diabetic retinopathy and its progression.

Data Highlights

Key Findings

• GDF15 levels in aqueous humor of PDR patients are significantly higher than in cataract controls.
• GDF15 levels in vitreous humor of PDR patients are markedly higher than in controls with macular hole or epiretinal membrane.
• There is a notable difference in GDF15 levels between vitreous humor and aqueous humor in PDR patients.
• GDF15 is involved in inflammatory responses and may correlate with the severity of diabetic retinopathy.
• This study provides preliminary evidence for further investigation of GDF15's role in the intraocular microenvironment of PDR.

Clinical Implications

The elevated levels of GDF15 in ocular fluids of PDR patients may indicate its role in the disease. Further research is needed to explore GDF15's involvement in diabetic retinopathy.

Conclusion

The study demonstrates significant upregulation of GDF15 in the ocular fluids of PDR patients. Further investigations are needed to elucidate the mechanisms involved.

Related Resources & Content

1. Frontiers, Elevated GDF15 in Ocular Fluids of Patients with Proliferative Diabetic Retinopathy, 2026 -- Abstract
2. Contact Lens Spectrum — DRY EYE DX AND TX
3. Optometric Management — Detect Outer Retina Impairment in Diabetes
4. Optometric Management — Combatting inflammation in diabetic retinopathy
5. Retinal Physician — Emerging Treatments for Diabetic Eye Disease: Update on Clinical Trials
6. Recommendations | Diabetic retinopathy: management and monitoring | Guidance | NICE
7. Optometric Management — Combatting inflammation in diabetic retinopathy
8. Optometric Management — Detect Outer Retina Impairment in Diabetes
9. Contact Lens Spectrum — DRY EYE DX AND TX
10. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial - PMC
11. Frontiers | Elevated GDF15 in Ocular Fluids of Patients with Proliferative Diabetic Retinopathy